Insider holders · CIK 0001228627
Opus Genetics, Inc. · IRD
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Chang Ho AhnDirector | 6,010,000 | 500,000 | 6,510,000 | Apr 12, 2017 · 5:26 pm EDT | Form 4 |
| Cam GallagherDirector | 2,800,111 | 83,000 | 2,883,111 | Sep 8, 2026 · 4:05 pm EDT | Form 4 |
| George MagrathChief Executive Officer | 2,048,485 | — | 2,048,485 | Sep 11, 2026 · 4:09 pm EDT | Form 4 |
| Benjamin R YerxaPresident | 704,106 | — | 704,106 | Jul 27, 2026 · 4:08 pm EDT | Form 4 |
| Robert E. GagnonChief Financial Officer | 556,375 | — | 556,375 | Sep 8, 2026 · 4:05 pm EDT | Form 4 |
| Tae Heum JeongChief Financial Officer | 505,000 | — | 505,000 | Jan 12, 2015 · 6:22 pm EST | Form 4 |
| Joseph K SchachleChief Operating Officer | 291,440 | — | 291,440 | Jul 27, 2026 · 4:07 pm EDT | Form 4 |
| Douglas J SwirskyPresident and CEO | 50,000 | — | 50,000 | Jan 30, 2019 · 7:32 am EST | Form 4 |
| Lisa NolanChief Business Officer | 23,250 | — | 23,250 | Mar 1, 2019 · 5:41 pm EST | Form 4 |
| Peter David SuzdakChief Executive Officer | 22,250 | — | 22,250 | Mar 2, 2018 · 4:26 pm EST | Form 4 |
| Ben Gil PriceDirector | 15,000 | — | 15,000 | Jan 31, 2019 · 7:56 am EST | Form 4 |
| Charles BeeverDirector | 11,000 | — | 11,000 | Feb 4, 2019 · 4:53 pm EST | Form 4 |
| Ely BenaimChief Medical Officer | 4,750 | — | 4,750 | Mar 1, 2019 · 5:35 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.